Jun 2019

Nuvastatic has obtained approval to commence phase 2 clinical study for colon cancer. This study is currently underway and expected to be completed by 3rd quarter 2020.

Nuvastatic has obtained approval to commence phase 2 clinical study for colon cancer. This study is currently underway and expected to be completed by 3rd quarter 2020.

Facebook Email